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The authors of the present article read a recent 
article by Shao et al. [1] published in the Resus-
citation Journal with interest. Indeed, since the 
beginning of the severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) epidemic, there have 
been 2,435,876 infected patients confirmed, with an 
observed level of mortality of nearly 8%. The study 
by Shao et al. [1] is of considerable importance as 
it is the first to present the survival of COVID-19 
patients after in-hospital cardiac arrest. The au-
thors both characterized the patients and compared 
a number of factors that may affect the return of 
spontaneous circulation, as well as 30-day survival.
In an extreme situation, such as a prevailing pan-
demic, extraordinary methods should be applied [2]. 
The decisions taken may often conflict with the 
general principle of “first do no harm” and with its 
intrinsic ethical values; however, medical person-
nel should take into account not only their patient, 
but also their own safety, as well as the safety of 
their other patients, families, and colleagues [3]. As 
in the case of SARS and MERS, the primary route 
of spreading COVID-19 is the droplet or direct con-
tact pathway [4, 5]. It is worth remembering that 
HCoV-SARS, HCoV-MERS, and SARS-CoV-2 can 
also be transmitted via environmental vectors [6]. 
Therefore, when contacting a patient with sus-
pected or, particularly, confirmed COVID-19, 
medical personnel should use personal protective 
equipment for aerosol generating procedures and 
all procedures regarding such a patient, including 
resuscitation, which should be performed in air-
borne infection isolation rooms.
Wang et al. [7] indicated that the time from the 
disease onset to death was shorter in people over 
70 years of age compared with younger patients 
(11.5 and 20 days, respectively). Yang et al. [8] 
observed that in COVID-19 patients, comorbidi-
ties and diagnosed underlying diseases, including 
hypertension and respiratory system and car-
diovascular diseases, may constitute risk factors 
for severe compared with the non-severe course 
of COVID-19. These results were confirmed in 
a study by Shao et al. [1], in which cardiac arrest 
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in people over 60 years of age was associated with 
a higher risk of death; similarly, the risk of hyper-
tension, the most common coexisting disease in 
this group, increased with age. The higher risk of 
death in the elderly with COVID-19 may be asso-
ciated with impaired immune response, which is 
further reduced by the effect of coronavirus.
Shao et al. [1] also referred to two important 
issues. Firstly, patients with COVID-19 pneumo-
nia should be monitored in intensive care units, 
which, compared with general wards, provide 
a higher chance of survival. Secondly, the survival 
of patients with non-shockable rhythms is below 
0.8%; this, considered herein, is the most impor-
tant concern. In this context, a question arises 
whether cardiopulmonary resuscitation should be 
conducted in each patient with COVID-19, expos-
ing medical personnel and their closest associates, 
or, in the case of elderly patients with initial non-
-shockable rhythms, resuscitation should not be 
undertaken. The answer to this question should 
be established through discussions in individual 
therapeutic teams.
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